NEUROBIOLOGICAL FACTORS INVOLVED IN ALZHEIMER'S DISEASE

Authors

DOI:

https://doi.org/10.47820/recima21.v4i12.4710

Keywords:

Alzheimer's disease; Neurobiology; Neurodegeneration

Abstract

Introduction: Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by memory loss and cognitive decline, profoundly affecting the quality of life of affected individuals and their caregivers. Objective: This study aims to carry out a literature review to synthesize the neurobiological aspects of AD, exploring studies published between 2013 and 2023, focusing on identifying genetic, environmental and neurobiological factors associated with the progression of the disease. Methodology: Scientific articles were considered in the databases PubMed, Scopus, Web of Science and ScienceDirect, using descriptors such as "Alzheimer's disease", "neurobiology", "neurodegeneration", "amyloid beta" and "tau protein". The selection involved analysis of titles, abstracts and full reading of articles, excluding studies prior to 2013 and those not focused on the neurobiological aspects of AD. Results and Discussion: The review highlighted the influence of genetic factors on susceptibility to AD, with the APOE ε4 gene and other variants associated with the risk of the disease. Environmental aspects, such as formal education and cardiovascular health, were associated with a lower risk. Neuroinflammation, oxidative stress, accumulation of toxic proteins, and synaptic dysfunction have emerged as key components in disease progression. Final Considerations: Advances in understanding the mechanisms underlying AD provide therapeutic and diagnostic perspectives. However, challenges persist, requiring specific biomarkers and more effective therapeutic strategies. The study highlights the need for multidisciplinary research to develop more effective interventions, aiming to alleviate the impact of AD not only on patients, but on society as a whole.

Downloads

Download data is not yet available.

Author Biographies

Lucas Mainardo Rodrigues Bezerra

Instituto de Educação Superior do Vale do Parnaíba - IESVAP.

Sedrik Pinheiro Pereira dos Santos, FAHESP/IESVAP

Acadêmico de Medicina do UNICEUMA.

Lisandra Azevedo Soares

Acadêmica de Medicina.

João Lucas Gomes Carvalho

Acadêmico de Medicina da FAHESP/IESVAP.

Paola Sthéfanie Gonçalves de Caldas

Acadêmico de Medicina da FAHESP/IESVAP

Plínio Rocha Oliveira

Acadêmico de Medicina do UNICEUMA.

Maria Clara Leal Pereira

Acadêmica de Medicina do Centro Universitário UniFacid/WYDEN.

Lusivânia de Brito Matos

Acadêmica de medicina da FAHESP/IESVAP.

References

Bellenguez C, et al. New insights on the genetic etiology of Alzheimer's and related dementia. MedRxiv. 2020.

Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148-160.

Cattaneo A, et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60-68.

Cummings J, et al. Alzheimer's disease drug development pipeline: 2021. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2021;7(1):e12179.

Gottesman RF, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurology. 2021;78(1):24-32.

Guerreiro R, et al. TREM2 variants in Alzheimer's disease. New England Journal of Medicine. 2013;368(2):117-127.

Henneka MT, et al. Neuroinflammation in Alzheimer's disease. The Lancet Neurology. 2015;14(4):388-405.

Jack Jr CR, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia. 2018;14(4):535-562.

Kunkle BW, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature genetics. 2019;51(3):414-430.

Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.

Liu CC, et al. Apolipoprotein E and Alzheimer's disease: risk, mechanisms, and therapy. Nat Rev Neurol. 2013;9(2):106-118.

Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019;179(2):312-339.

Long JM, Holtzman DM. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019;179(2):312-339.

Marsh J, Alifragis P. Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention. Neural regeneration research. 2018;13(4):616.

Masters CL, et al. Alzheimer's disease. Nature reviews disease primers. 2015;1(1):1-18.

Livingston G, et al. Dementia prevention, intervention, and care. The Lancet. 2017;390(10113):2673-2734.

Published

22/12/2023

How to Cite

Mainardo Rodrigues Bezerra, L., Pereira dos Santos, S. P., Azevedo Soares , L., Gomes Carvalho, J. L., Gonçalves de Caldas, P. S., Oliveira , P. R., … de Brito Matos , L. (2023). NEUROBIOLOGICAL FACTORS INVOLVED IN ALZHEIMER’S DISEASE. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 4(12), e4124710. https://doi.org/10.47820/recima21.v4i12.4710